Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.390
-0.170 (-10.90%)
At close: Jun 3, 2026, 4:00 PM EDT
1.400
+0.010 (0.72%)
After-hours: Jun 3, 2026, 7:44 PM EDT
Neuronetics Revenue
Neuronetics had revenue of $34.45M in the quarter ending March 31, 2026, with 7.75% growth. This brings the company's revenue in the last twelve months to $151.64M, up 69.52% year-over-year. In the year 2025, Neuronetics had annual revenue of $149.16M with 99.17% growth.
Revenue (ttm)
$151.64M
Revenue Growth
+69.52%
P/S Ratio
0.64
Revenue / Employee
$230,450
Employees
658
Market Cap
96.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 149.16M | 74.27M | 99.17% |
| Dec 31, 2024 | 74.89M | 3.54M | 4.96% |
| Dec 31, 2023 | 71.35M | 6.14M | 9.42% |
| Dec 31, 2022 | 65.21M | 9.89M | 17.89% |
| Dec 31, 2021 | 55.31M | 6.07M | 12.32% |
| Dec 31, 2020 | 49.24M | -13.41M | -21.41% |
| Dec 31, 2019 | 62.66M | 9.88M | 18.72% |
| Dec 31, 2018 | 52.78M | 12.34M | 30.53% |
| Dec 31, 2017 | 40.43M | 6.21M | 18.13% |
| Dec 31, 2016 | 34.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Outset Medical | 117.59M |
| Owlet | 107.06M |
| AVITA Medical | 72.35M |
| CVRx, Inc. | 59.07M |
| SANUWAVE Health | 44.34M |
| electroCore | 34.90M |
| Rapid Micro Biosystems | 34.38M |
| MaxCyte | 32.29M |
STIM News
- 1 day ago - Neuronetics Appoints Robert Greene as Senior Vice President Sales - GlobeNewsWire
- 1 day ago - Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026 - GlobeNewsWire
- 6 days ago - Neuronetics Transcript: AGM 2026 - Transcripts
- 20 days ago - Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment - GlobeNewsWire
- 4 weeks ago - Neuronetics reports Q1 EPS (16c), consensus (17c) - TheFly
- 4 weeks ago - Neuronetics backs FY26 revenue view $160M-$166M, consensus $162.47M - TheFly
- 4 weeks ago - Neuronetics Earnings Call Transcript: Q1 2026 - Transcripts
- 4 weeks ago - Neuronetics Earnings release: Q1 2026 - Filings